A detailed history of Dimensional Fund Advisors LP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,872,370 shares of PCRX stock, worth $35.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,872,370
Previous 1,828,065 2.42%
Holding current value
$35.9 Million
Previous $52.3 Million 46.09%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$11.7 - $28.46 $518,368 - $1.26 Million
44,305 Added 2.42%
1,872,370 $28.2 Million
Q2 2024

Aug 09, 2024

BUY
$25.5 - $31.51 $5.07 Million - $6.27 Million
198,936 Added 12.21%
1,828,065 $52.3 Million
Q1 2024

May 10, 2024

BUY
$27.7 - $35.48 $6.02 Million - $7.71 Million
217,362 Added 15.4%
1,629,129 $47.6 Million
Q4 2023

Feb 07, 2024

BUY
$26.32 - $34.31 $472,417 - $615,830
17,949 Added 1.29%
1,411,767 $47.6 Million
Q3 2023

Nov 09, 2023

BUY
$30.68 - $40.09 $8.33 Million - $10.9 Million
271,544 Added 24.2%
1,393,818 $42.8 Million
Q2 2023

Aug 09, 2023

BUY
$36.12 - $47.5 $4.81 Million - $6.32 Million
133,097 Added 13.46%
1,122,274 $45 Million
Q1 2023

May 12, 2023

BUY
$35.53 - $43.38 $1.49 Million - $1.81 Million
41,808 Added 4.41%
989,177 $40.4 Million
Q4 2022

Feb 09, 2023

BUY
$38.19 - $57.45 $2.68 Million - $4.03 Million
70,141 Added 8.0%
947,369 $36.6 Million
Q3 2022

Nov 10, 2022

BUY
$51.24 - $58.89 $3.48 Million - $4 Million
67,892 Added 8.39%
877,228 $46.7 Million
Q2 2022

Aug 12, 2022

BUY
$51.49 - $81.64 $2.62 Million - $4.16 Million
50,941 Added 6.72%
809,336 $47.2 Million
Q1 2022

May 13, 2022

BUY
$60.03 - $76.49 $216,228 - $275,516
3,602 Added 0.48%
758,395 $57.9 Million
Q4 2021

Feb 09, 2022

BUY
$47.97 - $62.21 $1.93 Million - $2.5 Million
40,191 Added 5.62%
754,793 $45.4 Million
Q3 2021

Nov 12, 2021

SELL
$54.64 - $61.3 $3.73 Million - $4.19 Million
-68,290 Reduced 8.72%
714,602 $40 Million
Q2 2021

Aug 12, 2021

BUY
$59.18 - $69.99 $10 Million - $11.9 Million
169,324 Added 27.6%
782,892 $47.5 Million
Q1 2021

May 14, 2021

BUY
$59.31 - $78.82 $2.24 Million - $2.98 Million
37,851 Added 6.57%
613,568 $43 Million
Q4 2020

Feb 25, 2021

BUY
$50.47 - $66.26 $29.1 Million - $38.1 Million
575,717 New
575,717 $34.4 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $880M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.